CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display

British Journal of Haematology

Volumn 111, Issue 1, 2000, Pages 157-166

  Miescher, Sylvia ^a   Zahn Zabal, Monique ^b   De Jesus, Maria ^c   Moudry, Radmila ^a   Fisch, Igor ^b   Vogel, Monique ^a   Kobr, Michel ^b   Imboden, Martin A ^a   Kragten, Eddy ^d   Bichler, Johann ^a   Mermod, Nicolas ^b   Stadler, Beda M ^a   Amstutz, Hanspeter ^a   Wurm, Florian ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Laboratory of Cellular Biotechnology   (Switzerland)

^d EPFL   (Switzerland)

Author keywords

Anti RhD(VI) antibodies; Bromelin; CHO expression; Phage

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; RECOMBINANT ANTIBODY; RHESUS D ANTIBODY;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ARTICLE; CELL SUSPENSION; CHEMOLUMINESCENCE; CHO CELL; CONTROLLED STUDY; HEMOLYSIS; LYMPHOCYTE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; SAFETY;

ANIMALS; BACTERIOPHAGES; BASE SEQUENCE; BIOTECHNOLOGY; BROMELAINS; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; ERYTHROCYTES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 0033764104     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02322.x     Document Type: Article

References (44)

1. Purification and partial characterization of the Mr 30,000 integral membrane protein associated with the erythrocyte Rh (D) antigen
2. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals
3. Immunochemical analysis of the human erythrocyte Rh polypeptides
4. Molecular analysis of Rh transcripts and polypeptides from individuals expressing the DVI variant phenotype: An RHD gene deletion event does not generate all DVIccEe phenotypes
5. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site
6. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
7. The ROHar RH: 33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene
8. In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells
9. Restricted use of cationic germline V (H) gene segments in human Rh (D) red cell antibodies
10. Production of human IgM anti-D in tissue culture by EB-virus-transformed lymphocytes
11. Production of human monoclonal antibody to rhesus D antigen
12. A chemiluminescence assay for erythrophagocytosis
13. Phage display used for gene cloning of human recombinant antibody against the erythrocyte surface antigen, rhesus D
14. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn
15. Transfecting mammalian cells: Optimization of critical parameters affecting calcium-phosphate precipitate formation
16. Continuous cultures of fused cells secreting antibody of predefined specificity
17. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF)
18. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn
19. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D
20. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D
21. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity
22. The gel test: A new way to detect red cell antigen-antibody reactions
23. Molecular cloning and primary structure of the human blood group RhD polypeptide
24. Determination of the true immunoreactive fraction of monoclonal antibodies after radio-labeling
25. Site-directed mutagenesis of the human D antigen: Definition of D epitopes on the sixth external domain of the D protein expressed on K562 cells
26. Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells
27. Cell bank characterization for recombinant DNA mammalian cell lines
28. Endogenous retroviruses of continuous cell substrates
29. Sequence and specificity analysis of recombinant human fab anti-Rh D isolated by phage display
30. Effects of methotrexate on transfected DNA stability in mammalian cells
31. Protective effect of the membrane skeleton on the immunologic reactivity of the human red cell Rho (D) antigen
32. Production of stable human-mouse hybridomas secreting monoclonal antibodies against Rh D and c antigens
33. A structural model for 30 Rh D epitopes based on serological and DNA sequence data from partial D phenotypes
34. Immunoprophylaxis for rhesus disease - Expensive but worth it?
35. The human immune response to red blood cell antigens as revealed by repertoire cloning
36. Expression and characterization of recombinant anti-Rh (D) antibodies on filamentous phage: A model system for isolating human red blood cell antibodies by repertoire cloning
37. Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: Applications in immunohematology
38. Characterisation of a chromatographically produced anti-D immunoglobulin product
39. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. I. Investigation of in vitro culture variables
40. Prediction of the outcome of rhesus haemolytic disease of the newborn: Additional information using an ADCC assay
41. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features
42. Chinese hamster ovary cells, recombinant protein production
43. The pathogenesis and prevention of Rh immunization